Detailed Information on Publication Record
2005
Our first experience in preimplantation genetic diagnosis.
VALÁŠKOVÁ, Iveta, Jitka KADLECOVÁ, Petr KUGLÍK, Iva SLÁMOVÁ, Renata GAILLYOVÁ et. al.Basic information
Original name
Our first experience in preimplantation genetic diagnosis.
Name in Czech
Naše první zkušenosti s preimplantační genetickou diagnostikou
Authors
VALÁŠKOVÁ, Iveta (203 Czech Republic), Jitka KADLECOVÁ (203 Czech Republic), Petr KUGLÍK (203 Czech Republic, guarantor), Iva SLÁMOVÁ (203 Czech Republic) and Renata GAILLYOVÁ (203 Czech Republic)
Edition
Praha, European Journal of Human Genetics, p. 268-268, 2005
Publisher
Nature Publishing Group
Other information
Language
English
Type of outcome
Stať ve sborníku
Field of Study
Biotechnology and bionics
Country of publisher
Czech Republic
Confidentiality degree
není předmětem státního či obchodního tajemství
RIV identification code
RIV/00216224:14310/05:00014636
Organization unit
Faculty of Science
ISBN
1018-4813
Keywords in English
PGD; chromosomal aberrations; FISH; PCR; cystic fibrosis
Tags
Změněno: 18/1/2007 13:57, doc. RNDr. Petr Kuglík, CSc.
V originále
Prevention of the birth of affected children in couples at risk for transmitting a genetic disorder is currently based on population screening and prenatal diagnosis, followed by termination of affected pregnancies. However, this is the most sensitive problem in the control of genetic disease, which is incompatible with life or not tolerated in populations and ethnic groups. Preimplantation genetic diagnosis (PGD) is a principally new approach for the prevention of genetic disorders, which allows the selection of unaffected IVF embryos for establishing pregnancies in couples at risk. PGD may be achieved by testing female gametes (polar body analysis), blastomeres from cleavage stage embryos, or blastocysts. PGD can be applied for monogenic disorders or chromosomal abnormalities, using diagnostic protocols based on the polymerase chain reaction (PCR) or fluorescence in situ hybridisation (FISH), respectively. Our genetic centre at present concentrates on chromosomal abnormalities, while also on genotyping for single-gene disorders. Genetic analyses are performed on biopsied blastomeres . PGD of chromosomal abnormalities is applied in patients with repeated IVF failures or spontaneous abortions. This application is essentially a screening procedure to detect aneuploidies/polyploidies or translocations most commonly observed postnatally or in spontaneus abortions. We optimise the first PCR based PGD protocol for genotyping of Cystic Fibrosis Transmembrane Regulator (CFTR) gene with focusing on several inherent difficulties associated with single cell DNA amplifications including potential sample contamination, total PCR failure and allelic drop out. These difficulties should be minimised for any PGD PCR protocol before clinical application.
In Czech
Práce se zabývá prvními zkušenostmi pracoviště OLG FN Brno a Laboratoře molekulární cytogenetiky PřF MU s preimplantační genetickou diagnostikou při vyšetřování početních i strukturních chromozomových abnormalit a některých monogenních onemocnění (cystická fibróza).
Links
MSM0021622415, plan (intention) |
|